GlaxoSmithKline (Jobs) Reports Rosiglitazone (Avandia) Linked To Fractures In Women

ROCKVILLE, Md., Feb. 21 -- The FDA informed physicians today of a report by GlaxoSmithKline of an increased number of arm, hand, and foot fractures among women taking rosiglitazone (Avandia) for newly diagnosed type 2 diabetes.